NextGen Healthcare Beheer
Beheer criteriumcontroles 3/4
De CEO NextGen Healthcare is David Sides, benoemd in Sep2021, heeft een ambtstermijn van 2.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.90M, bestaande uit 9% salaris en 91% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.91% van de aandelen van het bedrijf, ter waarde $ 14.65M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.5 jaar en 6.3 jaar.
Belangrijke informatie
David Sides
Algemeen directeur
US$7.9m
Totale compensatie
| Percentage CEO-salaris | 9.0% |
| Dienstverband CEO | 2.2yrs |
| Eigendom CEO | 0.9% |
| Management gemiddelde ambtstermijn | 5.5yrs |
| Gemiddelde ambtstermijn bestuur | 6.3yrs |
Recente managementupdates
Recent updates
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?
Aug 24
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 27Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist
Jul 13We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Jun 08Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)
May 19What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?
Mar 14We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Feb 27Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 08These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong
Oct 27At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?
Sep 30NextGen Enterprise solution to be used by NY-based health center
Sep 28NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price
Sep 07NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital
Jul 29NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates
Jul 26Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?
May 17NextGen At A Crossroads
Oct 13Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?
Jun 29Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$6m |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | US$8m | US$709k | -US$3m |
| Dec 31 2022 | n/a | n/a | US$23m |
| Sep 30 2022 | n/a | n/a | US$20m |
| Jun 30 2022 | n/a | n/a | -US$82k |
| Mar 31 2022 | US$16m | US$356k | US$2m |
Compensatie versus markt: De totale vergoeding ($USD 7.90M ) David } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.38M ).
Compensatie versus inkomsten: De vergoeding van David is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
David Sides (52 yo)
2.2yrs
Tenure
US$7,895,821
Compensatie
Mr. David William Sides serves as Chief Executive Officer and President at NextGen Healthcare, Inc. since September 22, 2021 and serves as its Director since October 13, 2021. He had been Chief Operating O...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 2.2yrs | US$7.90m | 0.91% $ 14.7m | |
| Executive VP & CFO | 7.7yrs | US$3.63m | 0.78% $ 12.5m | |
| Executive VP | 5.9yrs | US$1.63m | 0.14% $ 2.3m | |
| Executive Vice President of Commercial Growth | 1.8yrs | US$1.86m | 0.086% $ 1.4m | |
| Executive VP and Chief Growth & Strategy Officer | 1.3yrs | US$3.29m | 0.54% $ 8.7m | |
| Senior VP | 6.8yrs | geen gegevens | 0.066% $ 1.1m | |
| Chief Technology Officer | less than a year | geen gegevens | geen gegevens | |
| Chief Information & Security Officer | 10yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Marketing | 5.2yrs | geen gegevens | geen gegevens | |
| Executive Vice President of Human Resources | 5.9yrs | geen gegevens | 0.12% $ 1.9m | |
| Executive Vice President of Enterprise | 7.3yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer | 1.9yrs | geen gegevens | geen gegevens |
5.5yrs
Gemiddelde duur
59.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van NXGN is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.5 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 2.1yrs | US$7.90m | 0.91% $ 14.7m | |
| Independent Chairman | 9.5yrs | US$335.01k | 0.22% $ 3.6m | |
| Independent Director | 10.8yrs | US$272.00k | 0.15% $ 2.4m | |
| Independent Director | 2.1yrs | US$260.00k | 0.046% $ 742.8k | |
| Independent Director | 6.3yrs | US$272.50k | 0.10% $ 1.7m | |
| Independent Director | 15.2yrs | US$285.00k | 0.12% $ 2.0m | |
| Independent Vice Chairman | 14.2yrs | US$295.77k | 0.10% $ 1.6m | |
| Independent Director | 2.1yrs | US$265.00k | 0.046% $ 742.8k | |
| Independent Director | 2.3yrs | US$262.50k | 0.049% $ 787.1k |
6.3yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van NXGN wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.3 jaar).